Integrated modeling of digital-motor and clinician-reported outcomes using item response theory: towards powerful trials for rare neurological diseases

Robust and highly sensitive outcomes are crucial for small trials in rare diseases. Combining different outcome types might improve sensitivity to identify disease severity and progression, yet innovative methodologies are scarce. Here we develop an Item Response Theory framework that allows integra...

Full description

Saved in:
Bibliographic Details
Main Authors: Hamdan, Alzahra (Author) , Traschütz, Andreas (Author) , Beichert, Lukas (Author) , Chen, Xiaomei (Author) , Gagnon, Cynthia (Author) , van de Warrenburg, Bart P. (Author) , Santorelli, Filippo M. (Author) , Başak, Nazlı (Author) , Coarelli, Giulia (Author) , Horvath, Rita (Author) , Klebe, Stephan (Author) , Schüle-Freyer, Rebecca (Author) , Hooker, Andrew C. (Author) , Synofzik, Matthis (Author) , Karlsson, Mats O. (Author)
Format: Article (Journal)
Language:English
Published: November 2025
In: CPT: pharmacometrics & systems pharmacology
Year: 2025, Volume: 14, Issue: 11, Pages: 1857-1868
ISSN:2163-8306
DOI:10.1002/psp4.70081
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/psp4.70081
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/psp4.70081
Get full text
Author Notes:Alzahra Hamdan, Andreas Traschütz, Lukas Beichert, Xiaomei Chen, Cynthia Gagnon, Bart P. van de Warrenburg, Filippo M. Santorelli, Nazlı Başak, Giulia Coarelli, Rita Horvath, Stephan Klebe, Prospax Consortium, Evidence-Rnd Consortium, Rebecca Schüle, Andrew C. Hooker, Matthis Synofzik, Mats O. Karlsson

MARC

LEADER 00000naa a2200000 c 4500
001 1942682018
003 DE-627
005 20251127095423.0
007 cr uuu---uuuuu
008 251127s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/psp4.70081  |2 doi 
035 |a (DE-627)1942682018 
035 |a (DE-599)KXP1942682018 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hamdan, Alzahra  |e VerfasserIn  |0 (DE-588)136561588X  |0 (DE-627)1925668665  |4 aut 
245 1 0 |a Integrated modeling of digital-motor and clinician-reported outcomes using item response theory  |b towards powerful trials for rare neurological diseases  |c Alzahra Hamdan, Andreas Traschütz, Lukas Beichert, Xiaomei Chen, Cynthia Gagnon, Bart P. van de Warrenburg, Filippo M. Santorelli, Nazlı Başak, Giulia Coarelli, Rita Horvath, Stephan Klebe, Prospax Consortium, Evidence-Rnd Consortium, Rebecca Schüle, Andrew C. Hooker, Matthis Synofzik, Mats O. Karlsson 
264 1 |c November 2025 
300 |b Illustrationen 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 21. Juli 2025 
500 |a Gesehen am 27.11.2025 
520 |a Robust and highly sensitive outcomes are crucial for small trials in rare diseases. Combining different outcome types might improve sensitivity to identify disease severity and progression, yet innovative methodologies are scarce. Here we develop an Item Response Theory framework that allows integrated modeling of both continuous and categorical outcomes (ccIRT). With degenerative ataxias, a group of rare neurological coordination diseases, as a showcase, we developed a ccIRT model integrating two ataxia outcome types: a clinician-reported outcome (Scale for the Assessment and Rating of Ataxia; SARA; categorical data) and digital-motor outcomes for gait and limb coordination (continuous data). The ccIRT model leveraged data from 331 assessments from a natural history study for spastic ataxias. The model describes SARA items and digital-motor outcomes data as functions of a common underlying ataxia severity construct, evaluating 9 gait and 17 limb coordination digital-motor measures for their ability to add to SARA in estimating individual ataxia severity levels. Based on our proposed workflow for assessing digital-motor outcomes in ccIRT models, the final model selected three digital gait and three limb coordination measures, reducing average uncertainty in ataxia severity estimates by 49% (10% SD) compared to the SARA-only IRT model. Trial simulations showed a 49% and 61% reduction in sample sizes needed to detect disease-modifying effects in two genotypes. Overall, our ccIRT framework for combining multiple outcome domains, even of different variable types, facilitates a more precise estimation of disease severity and a higher power, which is particularly relevant for rare diseases with inherently small and short trials. Trial Registration: ClinicalTrials.gov: NCT04297891 
650 4 |a clinical outcome assessments 
650 4 |a digital-motor outcomes 
650 4 |a genetic ataxias 
650 4 |a Item Response Theory 
650 4 |a rare neurological diseases 
700 1 |a Traschütz, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Beichert, Lukas  |e VerfasserIn  |4 aut 
700 1 |a Chen, Xiaomei  |e VerfasserIn  |4 aut 
700 1 |a Gagnon, Cynthia  |e VerfasserIn  |4 aut 
700 1 |a van de Warrenburg, Bart P.  |e VerfasserIn  |4 aut 
700 1 |a Santorelli, Filippo M.  |e VerfasserIn  |4 aut 
700 1 |a Başak, Nazlı  |e VerfasserIn  |4 aut 
700 1 |a Coarelli, Giulia  |e VerfasserIn  |4 aut 
700 1 |a Horvath, Rita  |e VerfasserIn  |4 aut 
700 1 |a Klebe, Stephan  |e VerfasserIn  |4 aut 
700 1 |a Schüle-Freyer, Rebecca  |d 1975-  |e VerfasserIn  |0 (DE-588)137544472  |0 (DE-627)695848283  |0 (DE-576)30411118X  |4 aut 
700 1 |a Hooker, Andrew C.  |e VerfasserIn  |4 aut 
700 1 |a Synofzik, Matthis  |e VerfasserIn  |4 aut 
700 1 |a Karlsson, Mats O.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t CPT: pharmacometrics & systems pharmacology  |d London : Nature Publ. Group, 2012  |g 14(2025), 11 vom: Nov., Seite 1857-1868  |h Online-Ressource  |w (DE-627)733752829  |w (DE-600)2697010-7  |w (DE-576)377477370  |x 2163-8306  |7 nnas  |a Integrated modeling of digital-motor and clinician-reported outcomes using item response theory towards powerful trials for rare neurological diseases 
773 1 8 |g volume:14  |g year:2025  |g number:11  |g month:11  |g pages:1857-1868  |g extent:12  |a Integrated modeling of digital-motor and clinician-reported outcomes using item response theory towards powerful trials for rare neurological diseases 
856 4 0 |u https://doi.org/10.1002/psp4.70081  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/psp4.70081  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251127 
993 |a Article 
994 |a 2025 
998 |g 137544472  |a Schüle-Freyer, Rebecca  |m 137544472:Schüle-Freyer, Rebecca  |d 910000  |d 911100  |e 910000PS137544472  |e 911100PS137544472  |k 0/910000/  |k 1/910000/911100/  |p 12 
999 |a KXP-PPN1942682018  |e 4814753403 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Integrated modeling of digital-motor and clinician-reported outcomes using item response theory","subtitle":"towards powerful trials for rare neurological diseases","title_sort":"Integrated modeling of digital-motor and clinician-reported outcomes using item response theory"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S.","noteIll":"Illustrationen"}],"id":{"eki":["1942682018"],"doi":["10.1002/psp4.70081"]},"relHost":[{"recId":"733752829","title":[{"title_sort":"CPT: pharmacometrics & systems pharmacology","title":"CPT: pharmacometrics & systems pharmacology"}],"id":{"eki":["733752829"],"issn":["2163-8306"],"zdb":["2697010-7"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2012-","publisher":"Nature Publ. Group","publisherPlace":"London","dateIssuedKey":"2012"}],"language":["eng"],"part":{"volume":"14","year":"2025","text":"14(2025), 11 vom: Nov., Seite 1857-1868","issue":"11","pages":"1857-1868","extent":"12"},"note":["Gesehen am 22.01.15"],"pubHistory":["1.2012 -"],"disp":"Integrated modeling of digital-motor and clinician-reported outcomes using item response theory towards powerful trials for rare neurological diseasesCPT: pharmacometrics & systems pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"CPT: pharmacometrics and systems pharmacology"}]}],"origin":[{"dateIssuedDisp":"November 2025","dateIssuedKey":"2025"}],"language":["eng"],"name":{"displayForm":["Alzahra Hamdan, Andreas Traschütz, Lukas Beichert, Xiaomei Chen, Cynthia Gagnon, Bart P. van de Warrenburg, Filippo M. Santorelli, Nazlı Başak, Giulia Coarelli, Rita Horvath, Stephan Klebe, Prospax Consortium, Evidence-Rnd Consortium, Rebecca Schüle, Andrew C. Hooker, Matthis Synofzik, Mats O. Karlsson"]},"recId":"1942682018","person":[{"family":"Hamdan","role":"aut","display":"Hamdan, Alzahra","given":"Alzahra"},{"display":"Traschütz, Andreas","given":"Andreas","family":"Traschütz","role":"aut"},{"role":"aut","family":"Beichert","given":"Lukas","display":"Beichert, Lukas"},{"display":"Chen, Xiaomei","given":"Xiaomei","family":"Chen","role":"aut"},{"role":"aut","family":"Gagnon","display":"Gagnon, Cynthia","given":"Cynthia"},{"role":"aut","family":"van de Warrenburg","display":"van de Warrenburg, Bart P.","given":"Bart P."},{"display":"Santorelli, Filippo M.","given":"Filippo M.","role":"aut","family":"Santorelli"},{"given":"Nazlı","display":"Başak, Nazlı","family":"Başak","role":"aut"},{"display":"Coarelli, Giulia","given":"Giulia","family":"Coarelli","role":"aut"},{"family":"Horvath","role":"aut","display":"Horvath, Rita","given":"Rita"},{"family":"Klebe","role":"aut","given":"Stephan","display":"Klebe, Stephan"},{"given":"Rebecca","display":"Schüle-Freyer, Rebecca","role":"aut","family":"Schüle-Freyer"},{"role":"aut","family":"Hooker","display":"Hooker, Andrew C.","given":"Andrew C."},{"display":"Synofzik, Matthis","given":"Matthis","family":"Synofzik","role":"aut"},{"role":"aut","family":"Karlsson","display":"Karlsson, Mats O.","given":"Mats O."}],"note":["Zuerst veröffentlicht: 21. Juli 2025","Gesehen am 27.11.2025"]} 
SRT |a HAMDANALZAINTEGRATED2025